BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12116177)

  • 1. Combined genome and proteome approach to identify new susceptibility genes.
    Pociot F; Karlsen AE
    Am J Med Genet; 2002 May; 115(1):55-60. PubMed ID: 12116177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteome analysis--a novel approach to understand the pathogenesis of Type 1 diabetes mellitus.
    Karlsen AE; Sparre T; Nielsen K; Nerup J; Pociot F
    Dis Markers; 2001; 17(4):205-16. PubMed ID: 11790888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key beta cell gene signaling pathways involved in type 1 diabetes.
    Silva D; Petrovsky N
    Ann N Y Acad Sci; 2004 Dec; 1037():203-7. PubMed ID: 15699518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons on autoimmune diabetes from animal models.
    Yang Y; Santamaria P
    Clin Sci (Lond); 2006 Jun; 110(6):627-39. PubMed ID: 16689681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of genetic and non-genetic factors in type 1 diabetes.
    Hawa MI; Beyan H; Buckley LR; Leslie RD
    Am J Med Genet; 2002 May; 115(1):8-17. PubMed ID: 12116172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
    Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
    Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular genetics of type 1 diabetes mellitus: achievements and future trends].
    Nosikov VV; Seregin IuA
    Mol Biol (Mosk); 2008; 42(5):867-79. PubMed ID: 18988535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-mediated beta-cell destruction in vitro and in vivo-A pivotal role for galectin-3.
    Karlsen AE; Størling ZM; Sparre T; Larsen MR; Mahmood A; Størling J; Roepstorff P; Wrzesinski K; Larsen PM; Fey S; Nielsen K; Heding P; Ricordi C; Johannesen J; Kristiansen OP; Christensen UB; Kockum I; Luthman H; Nerup J; Pociot F
    Biochem Biophys Res Commun; 2006 May; 344(1):406-15. PubMed ID: 16600178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental factors in the etiology of type 1 diabetes.
    Akerblom HK; Vaarala O; Hyöty H; Ilonen J; Knip M
    Am J Med Genet; 2002 May; 115(1):18-29. PubMed ID: 12116173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy.
    Ichinose K; Kawasaki E; Eguchi K
    Am J Nephrol; 2007; 27(6):554-64. PubMed ID: 17823503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus.
    Tsirogianni A; Pipi E; Soufleros K
    Autoimmun Rev; 2009 Jul; 8(8):687-91. PubMed ID: 19217947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet regeneration needed for overcoming autoimmune destruction - considerations on the pathogenesis of type 1 diabetes.
    von Herrath M; Homann D
    Pediatr Diabetes; 2004; 5 Suppl 2():23-8. PubMed ID: 15601371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic profiling of beta-cells using a classical approach - two-dimensional gel electrophoresis.
    Süss C; Solimena M
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S13-20. PubMed ID: 18777447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is mortalin a candidate gene for T1DM ?
    Johannesen J; Pie A; Karlsen AE; Larsen ZM; Jensen A; Vissing H; Kristiansen OP; Pociot F; Nerup J; ;
    Autoimmunity; 2004; 37(6-7):423-30. PubMed ID: 15621568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes.
    Silveira PA; Grey ST
    Trends Endocrinol Metab; 2006; 17(4):128-35. PubMed ID: 16580840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early events in islets and pancreatic lymph nodes in autoimmune diabetes.
    Aspord C; Rome S; Thivolet C
    J Autoimmun; 2004 Aug; 23(1):27-35. PubMed ID: 15236750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice.
    Martin AP; Grisotto MG; Canasto-Chibuque C; Kunkel SL; Bromberg JS; Furtado GC; Lira SA
    Diabetes; 2008 Feb; 57(2):387-94. PubMed ID: 18003753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A look to the future: prediction, prevention, and cure including islet transplantation and stem cell therapy.
    Casu A; Trucco M; Pietropaolo M
    Pediatr Clin North Am; 2005 Dec; 52(6):1779-804. PubMed ID: 16301093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in type 1 diabetes.
    Taplin CE; Barker JM
    Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the target organ in cytokine-mediated beta-cell destruction. Possible relevance for the pathogenesis of insulin dependent diabetes mellitus.
    Andersen HU
    Dan Med Bull; 1999 Apr; 46(2):127-64. PubMed ID: 10327296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.